Wealth Effects’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $126K | Buy |
34,500
+2,500
| +8% | +$9.1K | 0.05% | 196 |
|
|
2025
Q1 | $61.4K | Hold |
32,000
| – | – | 0.03% | 196 |
|
|
2024
Q4 | $60.8K | Buy |
32,000
+5,000
| +19% | +$9.5K | 0.02% | 209 |
|
|
2024
Q3 | $35.6K | Hold |
27,000
| – | – | 0.01% | 214 |
|
|
2024
Q2 | $27.5K | Hold |
27,000
| – | – | 0.01% | 205 |
|
|
2024
Q1 | $49.4K | Sell |
27,000
-2,500
| -8% | -$4.58K | 0.02% | 214 |
|
|
2023
Q4 | $36.6K | Hold |
29,500
| – | – | 0.01% | 225 |
|
|
2023
Q3 | $33.6K | Buy |
29,500
+11,184
| +61% | +$12.8K | 0.02% | 190 |
|
|
2023
Q2 | $16.8K | Hold |
18,316
| – | – | 0.01% | 199 |
|
|
2023
Q1 | $10.3K | Hold |
18,316
| – | – | 0.01% | 197 |
|
|
2022
Q4 | $10.6K | Hold |
18,316
| – | – | 0.01% | 191 |
|
|
2022
Q3 | $6K | Hold |
18,316
| – | – | ﹤0.01% | 183 |
|
|
2022
Q2 | $6K | Sell |
18,316
-512
| -3% | -$168 | ﹤0.01% | 188 |
|
|
2022
Q1 | $14K | Buy |
+18,828
| New | +$14K | 0.01% | 203 |
|